Literature DB >> 14535845

Molecular basis of the high-affinity activation of type 1 ryanodine receptors by imperatoxin A.

Chul Won Lee1, Eun Hui Lee, Koh Takeuchi, Hideo Takahashi, Ichio Shimada, Kazuki Sato, Song Yub Shin, Do Han Kim, Jae Il Kim.   

Abstract

Both imperatoxin A (IpTx(a)), a 33-residue peptide toxin from scorpion venom, and peptide A, derived from the II-III loop of dihydropyridine receptor (DHPR), interact specifically with the skeletal ryanodine receptor (RyR1), which is a Ca(2+)-release channel in the sarcoplasmic reticulum, but with considerably different affinities. IpTx(a) activates RyR1 with nanomolar affinity, whereas peptide A activates RyR1 at micromolar concentrations. To investigate the molecular basis for high-affinity activation of RyR1 by IpTx(a), we have determined the NMR solution structure of IpTx(a), and identified its functional surface by using alanine-scanning analogues. A detailed comparison of the functional surface profiles for two peptide activators revealed that IpTx(a) exhibits a large functional surface area (approx. 1900 A(2), where 1 A=0.1 nm), based on a short double-stranded antiparallel beta-sheet structure, while peptide A bears a much smaller functional surface area (approx. 800 A(2)), with the five consecutive basic residues (Arg(681), Lys(682), Arg(683), Arg(684) and Lys(685)) being clustered at the C-terminal end of the alpha-helix. The functional surface of IpTx(a) is composed of six essential residues (Leu(7), Lys(22), Arg(23), Arg(24), Arg(31) and Arg(33)) and several other important residues (His(6), Lys(8), Arg(9), Lys(11), Lys(19), Lys(20), Gly(25), Thr(26), Asn(27) and Lys(30)), indicating that amino acid residues involved in RyR1 activation make up over the half of the toxin molecule with the exception of cysteine residues. Taken together, these results suggest that the site where peptide A binds to RyR1 belongs to a subset of macrosites capable of being occupied by IpTx(a), resulting in differing the affinity and the mode of activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14535845      PMCID: PMC1223873          DOI: 10.1042/BJ20031192

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  49 in total

1.  A new fold in the scorpion toxin family, associated with an activity on a ryanodine-sensitive calcium channel.

Authors:  A Mosbah; R Kharrat; Z Fajloun; J G Renisio; E Blanc; J M Sabatier; M El Ayeb; H Darbon
Journal:  Proteins       Date:  2000-08-15

2.  Coupling of RYR1 and L-type calcium channels via calmodulin binding domains.

Authors:  S Sencer; R V Papineni; D B Halling; P Pate; J Krol; J Z Zhang; S L Hamilton
Journal:  J Biol Chem       Date:  2001-08-10       Impact factor: 5.157

3.  The three-dimensional structural surface of two beta-sheet scorpion toxins mimics that of an alpha-helical dihydropyridine receptor segment.

Authors:  Daniel Green; Suzi Pace; Suzanne M Curtis; Magdalena Sakowska; Graham D Lamb; Angela F Dulhunty; Marco G Casarotto
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

4.  Structure of the voltage-gated L-type Ca2+ channel by electron cryomicroscopy.

Authors:  I I Serysheva; S J Ludtke; M R Baker; W Chiu; S L Hamilton
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

5.  PROMOTIF--a program to identify and analyze structural motifs in proteins.

Authors:  E G Hutchinson; J M Thornton
Journal:  Protein Sci       Date:  1996-02       Impact factor: 6.725

6.  Three-dimensional structure in solution of the calcium channel blocker omega-conotoxin.

Authors:  P K Pallaghy; B M Duggan; M W Pennington; R S Norton
Journal:  J Mol Biol       Date:  1993-11-20       Impact factor: 5.469

7.  Chemical synthesis and characterization of maurocalcine, a scorpion toxin that activates Ca(2+) release channel/ryanodine receptors.

Authors:  Z Fajloun; R Kharrat; L Chen; C Lecomte; E Di Luccio; D Bichet; M El Ayeb; H Rochat; P D Allen; I N Pessah; M De Waard; J M Sabatier
Journal:  FEBS Lett       Date:  2000-03-10       Impact factor: 4.124

8.  Maurocalcine and peptide A stabilize distinct subconductance states of ryanodine receptor type 1, revealing a proportional gating mechanism.

Authors:  Lili Chen; Eric Estève; Jean-Marc Sabatier; Michel Ronjat; Michel De Waard; Paul D Allen; Isaac N Pessah
Journal:  J Biol Chem       Date:  2003-02-13       Impact factor: 5.157

9.  A structural requirement for activation of skeletal ryanodine receptors by peptides of the dihydropyridine receptor II-III loop.

Authors:  M G Casarotto; F Gibson; S M Pace; S M Curtis; M Mulcair; A F Dulhunty
Journal:  J Biol Chem       Date:  2000-04-21       Impact factor: 5.157

10.  Three-dimensional location of the imperatoxin A binding site on the ryanodine receptor.

Authors:  M Samsó; R Trujillo; G B Gurrola; H H Valdivia; T Wagenknecht
Journal:  J Cell Biol       Date:  1999-07-26       Impact factor: 10.539

View more
  16 in total

1.  Maurocalcine and domain A of the II-III loop of the dihydropyridine receptor Cav 1.1 subunit share common binding sites on the skeletal ryanodine receptor.

Authors:  Xavier Altafaj; Weijun Cheng; Eric Estève; Julie Urbani; Didier Grunwald; Jean-Marc Sabatier; Roberto Coronado; Michel De Waard; Michel Ronjat
Journal:  J Biol Chem       Date:  2004-12-09       Impact factor: 5.157

2.  Charged surface area of maurocalcine determines its interaction with the skeletal ryanodine receptor.

Authors:  Balázs Lukács; Mónika Sztretye; János Almássy; Sándor Sárközi; Beatrix Dienes; Kamel Mabrouk; Cecilia Simut; László Szabó; Péter Szentesi; Michel De Waard; Michel Ronjat; István Jóna; László Csernoch
Journal:  Biophys J       Date:  2008-07-11       Impact factor: 4.033

3.  Recombinant expression of Intrepicalcin from the scorpion Vaejovis intrepidus and its effect on skeletal ryanodine receptors.

Authors:  Leonel Vargas-Jaimes; Liang Xiao; Jing Zhang; Lourival D Possani; Héctor H Valdivia; Verónica Quintero-Hernández
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-01-31       Impact factor: 3.770

4.  Unique scorpion toxin with a putative ancestral fold provides insight into evolution of the inhibitor cystine knot motif.

Authors:  Jennifer J Smith; Justine M Hill; Michelle J Little; Graham M Nicholson; Glenn F King; Paul F Alewood
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-13       Impact factor: 11.205

5.  Differential effects of maurocalcine on Ca2+ release events and depolarization-induced Ca2+ release in rat skeletal muscle.

Authors:  Henrietta Szappanos; Sophia Smida-Rezgui; Julianna Cseri; Cecilia Simut; Jean-Marc Sabatier; Michel De Waard; László Kovács; László Csernoch; Michel Ronjat
Journal:  J Physiol       Date:  2005-04-14       Impact factor: 5.182

6.  Transient loss of voltage control of Ca2+ release in the presence of maurocalcine in skeletal muscle.

Authors:  Sandrine Pouvreau; Laszlo Csernoch; Bruno Allard; Jean Marc Sabatier; Michel De Waard; Michel Ronjat; Vincent Jacquemond
Journal:  Biophys J       Date:  2006-06-16       Impact factor: 4.033

Review 7.  Toxin bioportides: exploring toxin biological activity and multifunctionality.

Authors:  Irina Kerkis; Alvaro Rossan de Brandão Prieto da Silva; Celine Pompeia; Jan Tytgat; Paulo L de Sá Junior
Journal:  Cell Mol Life Sci       Date:  2016-08-23       Impact factor: 9.261

8.  Characterization of hadrucalcin, a peptide from Hadrurus gertschi scorpion venom with pharmacological activity on ryanodine receptors.

Authors:  Elisabeth F Schwartz; E Michelle Capes; Elia Diego-García; Fernando Z Zamudio; Oscar Fuentes; Lourival D Possani; Héctor H Valdivia
Journal:  Br J Pharmacol       Date:  2009-04-16       Impact factor: 8.739

Review 9.  Scorpion venom components that affect ion-channels function.

Authors:  V Quintero-Hernández; J M Jiménez-Vargas; G B Gurrola; H H Valdivia; L D Possani
Journal:  Toxicon       Date:  2013-07-26       Impact factor: 3.033

10.  Ryanoids and imperatoxin affect the modulation of cardiac ryanodine receptors by dihydropyridine receptor Peptide A.

Authors:  Maura Porta; Paula L Diaz-Sylvester; Alma Nani; Josefina Ramos-Franco; Julio A Copello
Journal:  Biochim Biophys Acta       Date:  2008-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.